Hundreds of thousands of Brits who are vulnerable to Covid-19 have been offered hope of a return to normal life by a new injection of antibodies.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Evusheld, made by AstraZeneca, as the UK’s first drug which includes protective antibodies developed in a lab.
The treatment could be lifesaving for some of the half a million immunocompromised Brits who cannot get protection from Covid vaccines, such as cancer patients and organ donor recipients.
